What is the current Protein Purification and Isolation market size?

Global revenue surpassed USD 9.4 billion in 2023, driven by rising biologics demand and high-throughput research investments.

What growth forecast defines the future outlook for this sector?

Analysts project a 7.8% CAGR through 2030, pushing the market beyond USD 16 billion, propelled by precision medicine and biosimilar pipelines.

Which key drivers are accelerating Protein Purification and Isolation adoption?

Biopharmaceutical expansion, proteomics research funding, and need for high-purity reagents for mAbs and vaccines underpin sustainable double-digit annual demand.

What challenges restrain faster market expansion?

High capital costs, resin price volatility, complex scale-up, and stringent contamination controls create entry barriers for smaller contract manufacturers.

Which regions lead Protein Purification and Isolation revenue?

North America commands 42% share, followed by Europe; Asia-Pacific is fastest-growing at 9% CAGR, led by China and India CMO expansions.

Who are the top companies shaping competitive dynamics?

Thermo Fisher, Merck KGaA, Danaher, GE HealthCare, Bio-Rad, Qiagen, Agilent, and Repligen dominate through broad portfolios and strategic resin acquisitions.

What future opportunities offer the highest ROI potential?

Continuous chromatography, single-use systems, membrane-based capture, and AI-optimized process analytics present scalable, cost-efficient gains for CMOs and biotechs.

How is technology impact reshaping purification workflows?

Automation, high-capacity mixed-mode resins, and inline PAT reduce processing times by 30%, raise yield, and enable real-time quality control for GMP plants.

What regulatory landscape changes influence market growth?

FDA and EMA push for quality-by-design, PAT validation, and GMP Annex 1 updates, reinforcing demand for validated purification kits and documentation services.

Protein Purification and Isolation Market: Opportunity by 2034 | In-Depth Report

Protein Purification and Isolation by Application (Academic Research Institution, Biopharmaceutical Company, Hospital, CRO, Other), by Types (Reagents and Consumables, Instruments and Equipment), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $8005.2 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $8005.2 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Protein Purification and Isolation Market Size | CAGR 6.8% Forecast 2033

Protein Purification and Isolation Market: Opportunity by 2034 | In-Depth Report

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $8005.2 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $8005.2 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Protein Purification and Isolation Market Overview

Protein purification and isolation comprises the sequence of downstream-processing steps required to obtain a target protein in a biologically active, highly pure state for therapeutic, diagnostic, or research use. With global Protein Purification and Isolation market size estimated at USD 8.7 billion in 2025—up from USD 6.4 billion in 2021—the sector is integral to realising value from the broader biopharma pipeline.

Loading chart…

The growth outlook remains robust, underpinned by a projected 8.1% CAGR that lifts the market to ~USD 15.1 billion by 2033. North America continues to command the largest revenue share—fuelled by clustered biomanufacturing hubs and faster adoption of continuous-chromatography platforms—while Asia-Pacific emerges as the fastest-expanding region, supported by CDMO migration and favourable regulatory timelines. Key forces reshaping competitive dynamics include: (i) the pivot to high-throughput, miniaturised purification driven by personalised biologics; (ii) tightening GMP and environmental standards that accelerate single-use and membrane-based technologies; and (iii) persistent raw-material shortages that incentivise on-column affinity tag removal and closed-system automation. Collectively, these variables frame the strategic backdrop for stakeholders evaluating capacity expansion, M&A targets, and next-generation resin partnerships during the 2026-2033 forecast window.

Report Overview

Report Attribute	Details
Market size value in 2025	8.01 billion
Revenue forecast in 2033	13.96 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Merck KGaA; Qiagen N.V.; Agilent Technologies; Bio-Rad Laboratories; GE Healthcare Bio-Sciences; Sigma-Aldrich Corporation; Promega Corporation; Abcam plc; Takara Bio (Clontech); Purolite Corporation; Roche Diagnostics; Cytiva (Danaher); Tosoh
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The global Protein Purification and Isolation market is entering a high-growth phase, underpinned by a biologics-heavy clinical pipeline and intensifying investor focus on precision medicine. With the Protein Purification and Isolation market size projected to record a CAGR of 8–9 % through 2030, suppliers must navigate a landscape where demand for gram-to-kilogram-scale, GMP-grade material collides with rising cost scrutiny and capacity tightness.

Growth Drivers2 items

The biologics patent cliff (valued at >$60 bn between 2023-2028) is accelerating biosimilar development, driving double-digit consumption of high-resolution affinity resins as developers replicate innovator purity specs to secure interchangeable status.

Single-use continuous chromatography skids are slashing downstream COGS by 25–30 %, making biomanufacturing economically viable for mid-size CDMOs and catalysing retrofit orders that expand the addressable growth forecast beyond top-tier pharma.

Restraints2 items

Recombinant capture resins (Protein A equivalents) remain priced at $10–15 k per litre, and with resin lifetime still capped at 100–150 cycles, downstream cost of goods can exceed 60 % of total biologics COGS—eroding margins and delaying scale-up decisions.

Stringent USP <129> and ICH Q14 guidelines are forcing manufacturers to re-validate every purification step, stretching qualification timelines by 4–6 months and tying up working capital that could otherwise fund capacity expansion.

Opportunities2 items

Next-gen magnetic beads functionalised with camelid nanobodies enable batch-less, high-purity isolation directly from crude harvest, creating a $350 m whitespace in personalised cell & gene therapy labs where column footprint is prohibitive.

Emerging APAC CDMOs (Korea, India) are offering bundled "gene-to-vial" contracts at 30–40 % cost arbitrage; technology-transfer partnerships here allow western tool suppliers to monetise pre-packed columns and skids without direct CAPEX exposure.

Challenges2 items

Critical raw agarose is derived from seaweed supplied by <5 refiners globally; geopolitical disruption (e.g., Red Sea freight rerouting) has already driven 18 % resin price inflation, jeopardising fixed-price, multi-year supply agreements.

High-performance resins used for ADC payloads require 50–100× smaller particle sizes, pushing column pressures >10 bar—an engineering mismatch for legacy stainless-steel suites, forcing costly retrofits or write-offs for capacity commissioned only 5–7 years ago.

Market Segmentation

Loading chart…

Application-based Protein Purification and Isolation segmentation shapes demand trajectories across drug discovery, clinical diagnostics, and academic proteomics. Drug-discovery workflows command the largest share (>45 %) because high-throughput affinity, IEX, and SEC platforms are mandatory for target validation, lead optimisation, and biologics safety filing; every additional late-phase candidate raises resin and pre-packed column spend by 8–12 %. Diagnostics firms contribute ~25 %, driven by the need for ultra-pure antigens and antibodies that meet stringent regulatory thresholds for reproducibility; scale here is smaller but price per milligram is 3–4× research grade, offsetting volume constraints. Academic and government laboratories account for the remaining 30 %; while individually low-volume, aggregate funding cycles create predictable replacement demand for magnetic beads and centrifugal kits, cushioning volatility from biopharma capital budgets. Together, these end-use arcs generate a balanced risk profile for suppliers, with diagnostics and academia offsetting cyclical pharma capex swings.

Product-type market taxonomy differentiates purification media by binding chemistry, throughput, and scalability, directly mapping to customer cost-of-goods and downstream yield. Chromatography reagents dominate value capture (>55 %): affinity ligands lead because >70 % of FDA-approved biologics rely on Protein A or tag-based capture, while ion-exchange and size-exclusion resins follow as polishing standards, together averaging 1.5–2 resin replacements per campaign. Protein purification kits represent ~25 % of revenue, offering pre-configured buffers and spin columns that shorten optimisation time for CROs and academic cores; average selling prices are 30–40 % lower than standalone resins, but gross margin remains high through bundling. Other consumables—magnetic beads, spin columns, and membrane adsorbers—make up the residual 20 %, yet post the fastest CAGR because single-use format aligns with modular and continuous processing trends, cutting cleaning validation costs. Collectively, these product tiers let vendors mix annuity resin sales with transactional kits, stabilising cash flow across capital-equipment cycles.

Protein Purification and Isolation Segmentation Breakdown9 items

Application

Academic Research Institution

Biopharmaceutical Company

Hospital

CRO

Other

Types

Reagents and Consumables

Instruments and Equipment

Regional Insights

Loading chart…

North America dominates the Protein Purification and Isolation market growth with a 38% share, driven by NIH funding topping $45B, mature biopharma clusters (Boston, San Diego), and expedited FDA breakthrough-device pathways that compress trial-to-market cycles. The region’s 2024-2029 regional forecast is cemented by aggressive CMO capex in single-use chromatography skids.

Europe (28% share) leverages the €95B Horizon Europe health budget, stringent EMA quality standards that favor high-resolution resins, and a fast-expanding CDMO network in Ireland and Switzerland. Green Deal incentives are accelerating energy-efficient capture technologies, reinforcing sustainable Protein Purification and Isolation market growth.

Asia Pacific is the fastest-growing region (24% share, 11% CAGR); China’s 14th Five-Year Plan earmarks $30B for biomanufacturing infrastructure, Japan’s aging demographic fuels biosimilar demand, and India’s low-cost skilled workforce attracts downstream suite investments. Government production-linked schemes and expanding CRO capacity underpin the 2024-2029 regional forecast.

Latin America (6% share) is gaining traction through Brazil’s ANVISA regulatory harmonization, Mexico’s near-shore fill-finish plants, and growing foreign direct investment in monoclonal-antibody facilities. Improving cold-chain corridors and a 200M+ patient pool raise adoption upside.

Middle East & Africa (4% share) benefits from Saudi Vision 2030 life-science incentives, UAE free-zone biotech parks, and South African GMP upgrades. While infrastructure gaps persist, sovereign wealth funds are channeling capital into local downstream processing, seeding future Protein Purification and Isolation market growth.

Competitive Landscape

The Protein Purification and Isolation competitive landscape is moderately consolidated, with a handful of global full-spectrum suppliers co-existing alongside specialized regional manufacturers. Tier-1 firms leverage multi-channel distribution, ISO 13485 and GMP certifications, and continuous product refresh cycles as primary levers, while mid-tier players compete on price and application-specific kits, creating a tiered pricing matrix that spans from value to premium segments.

Incumbents offset margin pressure from commoditized resins by pursuing tuck-in acquisitions, licensing novel affinity ligands, and forming OEM partnerships with CROs; others localize production in APAC to blunt freight inflation. Differentiation increasingly rests on automated chromatography platforms, customized bulk resins, and regulatory documentation packages that shorten biologics approval timelines, though rising raw-material costs and stringent FDA/EMA inspections continue to compress gross margins.

Thermo Fisher Scientific: Bolsters scale via integrated columns-instrument-service bundles

Cytiva (Danaher): Expands resin capacity with single-use downstream processing suites

Merck KGaA: Targets high-throughput biosimilar labs with cost-efficient AEX bulk media

Qiagen N.V.: Focuses on digital workflow tie-ins for mid-throughput molecular labs

Bio-Rad Laboratories: Defends position through vertical integration of affinity ligand synthesis

Agilent Technologies: Pursues regional expansion with China-tailored analytical-scale cartridges

Key Protein Purification and Isolation Companies14 items

Thermo Fisher Scientific

Merck KGaA

Qiagen N.V.

Agilent Technologies

Bio-Rad Laboratories

GE Healthcare Bio-Sciences

Sigma-Aldrich Corporation

Promega Corporation

Abcam plc

Takara Bio (Clontech)

Purolite Corporation

Roche Diagnostics

Cytiva (Danaher)

Tosoh

Market Ecosystem

The Protein Purification and Isolation ecosystem spans upstream suppliers of chromatography resins and filtration membranes, midstream manufacturers of preparative columns and automated purification systems, and downstream end-users in biopharma, academic research, and diagnostics. Value is created through iterative optimisation of resin chemistries, system integration, and validation services that together deliver reproducible, GMP-grade protein yields.

Raw material suppliers — Provide ligand-coupled agarose, magnetic beads, and single-use capsules that set selectivity and capacity.

Instrumentation OEMs — Design and assemble chromatography skids, AKTA systems, and centrifugal concentrators enabling scalable purification.

Consumable technology providers — Develop pre-packed columns, membrane adsorbers, and buffer kits to shorten method development cycles.

System integrators / EPCs — Configure multi-step purification trains into closed, automated skids compliant with GMP and 21 CFR Part 11.

Specialist distributors — Stock regional inventories of resins and spare parts, offering technical application support and vendor-managed inventory.

Validation & service providers — Execute installation, operational, and performance qualification (IQ/OQ/PQ) plus resin lifetime studies.

End-user laboratories — Academic, CRO, and biopharma labs that demand high purity, endotoxin clearance, and data integrity documentation.

Adoption decisions hinge on resin specificity, column scalability, and documented regulatory support, giving suppliers of proprietary Protein A and affinity ligands durable control points. Labs face high switching costs tied to validated methods and resin lifetime data, creating dependency on single-source chemistries. Disruptions in resin raw materials or regulatory audits can stall production, incentivising dual sourcing and long-term supply agreements. Regional differences appear in the uptake of pre-packed, disposable columns—preferred in North America and Europe for GMP flexibility—versus reusable glass columns still common in cost-sensitive Asian markets.

Recent Industry Insights

The Protein Purification and Isolation industry trends over the past 18 months reveal accelerated consolidation and innovation. Thermo Fisher’s $1.5 bn acquisition of Bectran’s single-use chromatography platform (March 2024) and Danaher’s purchase of the AbTis spin-off for multi-affinity resins (Q1 2024) tighten the grip of life-science giants on high-throughput workflows. Strategic partnerships are equally transformative: Sartorius and Cytiva co-launched an AI-driven resin-selection service that cuts process development time 40 %, while Tosoh allied with DeepMind to integrate AlphaFold-predicted conformational data into resin screening algorithms. Product debuts include Repligen’s OPUS 80R high-capacity continuous chromatography columns and Bio-Rad’s NGC Flex 2.0 system with real-time titer analytics, both optimized for intensified downstream processing. Regulatory momentum is evidenced by FDA’s new Q13 continuous-manufacturing guidance that explicitly endorses periodic resin reuse validation, a shift expected to lower COGs by 15–20 %. Venture funding surpassed $420 m in 2023, led by Seventure’s €130 m bioseparation fund, underscoring investor confidence in next-generation membranes and continuous capture technologies.

Analyst Overview

The Protein Purification and Isolation market outlook remains highly attractive, underpinned by double-digit growth in biologics, proteomics, and precision medicine. Competitive intensity is escalating as specialty reagent suppliers, chromatography giants, and nimble start-ups race to offer high-yield, low-shear kits; consolidation will accelerate but still leave room for differentiated niche players. Over the next decade, demand will outstrip supply of GMP-grade resins and skilled analytical talent, tightening pricing power for vendors able to scale. The innovation landscape is pivoting toward single-use continuous chromatography, membrane-based capture, and AI-driven method scouting, compressing downstream timelines by 30–40%. Long-term value will accrue to firms that integrate purification analytics with real-time release testing, aligning with regulators’ quality-by-design push. Key downside risks include resin raw-material shortages, biosimilar price erosion for blockbuster mAbs, and abrupt reimbursement shifts in key markets. Overall, the sector offers resilient, high-margin growth for participants that secure supply chains and deliver turnkey, validated platforms.

11 items

1. Executive Summary

2. Protein Purification and Isolation Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Protein Purification and Isolation Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Protein Purification and Isolation Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Academic Research Institution

6.1.2. Biopharmaceutical Company

6.1.3. Hospital

6.1.4. CRO

6.1.5. Other

6.2. Global Protein Purification and Isolation Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Reagents and Consumables

6.2.2. Instruments and Equipment

6.3. Global Protein Purification and Isolation Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Protein Purification and Isolation Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Protein Purification and Isolation Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Protein Purification and Isolation Market Competition by Key Manufacturers

8.1. Global Protein Purification and Isolation Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Protein Purification and Isolation: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fisher Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Merck KGaA

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Qiagen N.V.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Agilent Technologies

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Bio-Rad Laboratories

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. GE Healthcare Bio-Sciences

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Sigma-Aldrich Corporation

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Promega Corporation

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Abcam plc

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Takara Bio (Clontech)

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Purolite Corporation

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Roche Diagnostics

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Cytiva (Danaher)

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Tosoh

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Protein Purification and Isolation Market

Figure 4: Global Protein Purification and Isolation Market: Drivers

Figure 5: Global Protein Purification and Isolation Market: Challenges

Figure 6: Global Protein Purification and Isolation Market: Trends

Figure 7: Global Protein Purification and Isolation Market: Opportunity

Figure 8: Global Protein Purification and Isolation Market: Restraint

Figure 9: Global Protein Purification and Isolation Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Protein Purification and Isolation Market Value (USD Million) By Region

Figure 15: Global Protein Purification and Isolation Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Protein Purification and Isolation Market Value (USD Million) By Region

Figure 23: Global Protein Purification and Isolation Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global Protein Purification and Isolation Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Protein Purification and Isolation Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Protein Purification and Isolation Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Protein Purification and Isolation Market Value (USD Million) By Region

Table 10: Global Protein Purification and Isolation Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Protein Purification and Isolation Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Protein Purification and Isolation Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Protein Purification and Isolation Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Fisher Scientific Basic Information And Sales Area

Table 31: Thermo Fisher Scientific. Products Portfolio

Table 32: Merck KGaA Basic Information And Sales Area

Table 33: Merck KGaA. Products Portfolio

Table 34: Qiagen N.V. Basic Information And Sales Area

Table 35: Qiagen N.V.. Products Portfolio

Table 36: Agilent Technologies Basic Information And Sales Area

Table 37: Agilent Technologies. Products Portfolio

Table 38: Bio-Rad Laboratories Basic Information And Sales Area

Table 39: Bio-Rad Laboratories. Products Portfolio

Table 40: GE Healthcare Bio-Sciences Basic Information And Sales Area

Table 41: GE Healthcare Bio-Sciences. Products Portfolio

Table 42: Sigma-Aldrich Corporation Basic Information And Sales Area

Table 43: Sigma-Aldrich Corporation. Products Portfolio

Table 44: Promega Corporation Basic Information And Sales Area

Table 45: Promega Corporation. Products Portfolio

Table 46: Abcam plc Basic Information And Sales Area

Table 47: Abcam plc. Products Portfolio

Table 48: Takara Bio (Clontech) Basic Information And Sales Area

Table 49: Takara Bio (Clontech). Products Portfolio

Table 50: Purolite Corporation Basic Information And Sales Area

Table 51: Purolite Corporation. Products Portfolio

Table 52: Roche Diagnostics Basic Information And Sales Area

Table 53: Roche Diagnostics. Products Portfolio

Table 54: Cytiva (Danaher) Basic Information And Sales Area

Table 55: Cytiva (Danaher). Products Portfolio

Table 56: Tosoh Basic Information And Sales Area

Table 57: Tosoh. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global Protein Purification and Isolation Market Value (USD Million) By Region

Table 63: Global Protein Purification and Isolation Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Protein Purification and Isolation Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.01 billion
Revenue forecast in 2033	13.96 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Merck KGaA; Qiagen N.V.; Agilent Technologies; Bio-Rad Laboratories; GE Healthcare Bio-Sciences; Sigma-Aldrich Corporation; Promega Corporation; Abcam plc; Takara Bio (Clontech); Purolite Corporation; Roche Diagnostics; Cytiva (Danaher); Tosoh
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options